1. Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years
   Ayanda M. Magwenyane et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
2. Therapeutic potential of marine peptides in malignant melanoma
   Salman Ahmed et al, 2023, Environmental Research CrossRef
3. A LY-15, a novel cyclic pentapeptide that inhibits B16 cell proliferation and migration and induces cell apoptosis
   Xuan Wang et al, 2018, Oncology Letters CrossRef
4. Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model
   Araceli Tobío et al, 2016, PLOS ONE CrossRef
5. Anti-cancer properties of Sansalvamide A, its derivatives, and analogs: an updated review
   Bharat Kumar Chagaleti et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
6. An update on the status of HSP90 inhibitors in cancer clinical trials
   Shraddha Rastogi et al, 2024, Cell Stress and Chaperones CrossRef
7. Heat shock proteins and cancer: The FoxM1 connection
   Zahra Alimardan et al, 2023, Biochemical Pharmacology CrossRef
8. Inhibitors of HSP90 in melanoma
   Aleksandra Mielczarek-Lewandowska et al, 2020, Apoptosis CrossRef